Effect of Clarithromycin and Rifampicin on the Pharmacokinetics of XZP-3287 in Healthy Subjects
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This is a phase I study to assess the drug-drug interaction of XZP-3287 and
Clarithromycin/Rifampicin. The study also evaluates the pharmacokinetic and tolerability of
XZP-3287 in healthy subjects.